Myasthenia gravis is treated with indirect-acting cholinergic agents that
a. Lead to accumulation of acetylcholine in the synaptic cleft.
b. Block the GI effects of the disease, allowing for absorption.
c. Directly stimulate the remaining acetylcholine receptors.
d. Can be given only by injection because of problems associated with swallowing.
Authors: Amy M. Karch